(Q35019228)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12470569%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

review article

1 reference

title

The place of gonadotrophin-releasing hormone antagonists in reproductive medicine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12470569%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

author name string

Colin M Howles

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12470569%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

publication date

1 January 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12470569%20AND%20SRC:MED&resulttype=core&format=json

Reproductive BioMedicine Online

15 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12470569%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

volume

4 Suppl 3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12470569%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

page(s)

64-71

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12470569%20AND%20SRC:MED&resulttype=core&format=json

Addition of GnRH antagonist in cycles of poor responders undergoing IVF.

15 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2812%2960120-5

7 January 2021

Comparison of agonistic flare-up-protocol and antagonistic multiple dose protocol in ovarian stimulation of poor responders: results of a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2812%2960120-5

7 January 2021

Comparison of different doses of gonadotropin-releasing hormone antagonist Cetrorelix during controlled ovarian hyperstimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2812%2960120-5

7 January 2021

Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2812%2960120-5

7 January 2021

Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2812%2960120-5

7 January 2021

Will GnRH antagonists provide new hope for patients considered 'difficult responders' to GnRH agonist protocols?

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2812%2960120-5

7 January 2021

Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist Cetrorelix during ovarian stimulation.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2812%2960120-5

7 January 2021

Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2812%2960120-5

7 January 2021

Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2812%2960120-5

7 January 2021

Embryo implantation and GnRH antagonists: embryo implantation: the Rubicon for GnRH antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2812%2960120-5

7 January 2021

Follicular development and early luteal function of conception and non-conceptional cycles after human in-vitro fertilization: endocrine correlates

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2812%2960120-5

7 January 2021

Gonadotropin-releasing-hormone-receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2812%2960120-5

7 January 2021

Embryo implantation and GnRH antagonists: GnRH antagonists in ART: lower embryo implantation?

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2812%2960120-5

7 January 2021

Significant reduction of the incidence of ovarian hyperstimulation syndrome (OHSS) by using the LHRH antagonist Cetrorelix (Cetrotide) in controlled ovarian stimulation for assisted reproduction.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2812%2960120-5

7 January 2021

Use of GnRH antagonists in ovarian stimulation for assisted reproductive technologies compared to the long protocol. Meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2812%2960120-5

7 January 2021

Health of 227 children born after controlled ovarian stimulation for in vitro fertilization using the luteinizing hormone-releasing hormone antagonist cetrorelix

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2812%2960120-5

7 January 2021

A randomized three-way cross-over study in healthy pituitary-suppressed women to compare the bioavailability of human chorionic gonadotrophin (Pregnyl) after intramuscular and subcutaneous administration

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2812%2960120-5

7 January 2021

The use of a GnRH antagonist (Cetrorelix) in a single dose protocol in IVF-embryo transfer: a dose finding study of 3 versus 2 mg

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2812%2960120-5

7 January 2021

Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin).

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2812%2960120-5

7 January 2021

Induction of ovulation after gnRH antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2812%2960120-5

7 January 2021

Complications of assisted reproductive techniques.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2812%2960120-5

7 January 2021

The use of gonadotrophin releasing hormone agonists for in vitro fertilization and other assisted procreation techniques: experience from three centres

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2812%2960120-5

7 January 2021

Reduced in-vitro fertilization of human oocytes from patients with raised basal luteinizing hormone levels during the follicular phase

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2812%2960120-5

7 January 2021

A prospective, randomized comparison of two starting doses of recombinant FSH in combination with cetrorelix in women undergoing ovarian stimulation for IVF/ICSI.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2812%2960120-5

7 January 2021

10.1016/S1472-6483(12)60120-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12470569%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

1 reference